Clinical Trial Update: Efficacy Study of Additional Intraperitoneal Chemotherapy to Treat Ovarian Cancer [Phase 2]

View source ↗

Summary

A Phase 2 efficacy study evaluating additional intraperitoneal chemotherapy for ovarian neoplasms was terminated; no results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Neoplasms

Snippet

Sponsor: Korea Cancer Center Hospital | Conditions: Ovarian Neoplasms | Phase 2 | Status: TERMINATED